A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

Completed · Phase 2

Conditions studied: Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Chronic Lymphocytic Leukemia

In brief

The purpose of this study is to determine the side effects and antitumor response of patients with lymphoid malignancies to Deoxycoformycin (DCF)/Pentostatin.

Key facts

Study ID
NCT00038025
Run by
M.D. Anderson Cancer Center
People needed
60
Starts
1994-09-06
Expected to finish
2006-11-29
Last updated by the study team
2018-11-16

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.